Dominant-negative mutant hepatocyte nuclear factor 1alpha induces diabetes in transgenic-cloned pigs.
about
Current progress of genetically engineered pig models for biomedical researchGermline transgenic pigs by Sleeping Beauty transposition in porcine zygotes and targeted integration in the pig genomePorcine model of hemophilia ATransgenesis for pig modelsFactors influencing the efficiency of generating genetically engineered pigs by nuclear transfer: multi-factorial analysis of a large data set.Transgenic pigs with pancreas-specific expression of green fluorescent protein.Generation of interleukin-2 receptor gamma gene knockout pigs from somatic cells genetically modified by zinc finger nuclease-encoding mRNADiffuse glomerular nodular lesions in diabetic pigs carrying a dominant-negative mutant hepatocyte nuclear factor 1-alpha, an inheritant diabetic gene in humans.Genetically engineered pig models for human diseases.Adult porcine genome-wide DNA methylation patterns support pigs as a biomedical model.Production of transgenic cloned pigs expressing the far-red fluorescent protein monomeric Plum.Generation of α1,3-galactosyltransferase and cytidine monophospho-N-acetylneuraminic acid hydroxylase gene double-knockout pigs.Developments in techniques for the isolation, enrichment, main culture conditions and identification of spermatogonial stem cellsMulti‑transgenic minipig models exhibiting potential for hepatic insulin resistance and pancreatic apoptosisGenetic modifications of pigs for medicine and agriculture.Germline modification of domestic animals.Production of diabetic offspring using cryopreserved epididymal sperm by in vitro fertilization and intrafallopian insemination techniques in transgenic pigs.Advances in porcine genomics and proteomics--a toolbox for developing the pig as a model organism for molecular biomedical research.Recent advances in the use of Sus scrofa (pig) as a model system for proteomic studies.Genetically modified pigs for biomedical research.Domestic animal models for biomedical research.Advancing pig cloning technologies towards application in regenerative medicine.Genetically engineered pig models for diabetes research.Genetically modified pigs to model human diseases.Genetically engineered livestock for biomedical models.Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases.Generation of human organs in pigs via interspecies blastocyst complementation.Permanent neonatal diabetes in INS(C94Y) transgenic pigs.Hollow fiber vitrification provides a novel method for cryopreserving in vitro maturation/fertilization-derived porcine embryos.Characterization of the porcine FBX07 gene: the first step towards generation of a pig model for Parkinsonian pyramidal syndrome.Characterization of the ICSI-mediated gene transfer method in the production of transgenic pigs.The creation of transgenic pigs expressing human proteins using BAC-derived, full-length genes and intracytoplasmic sperm injection-mediated gene transfer.Genetically engineered pigs as models for human disease.In vitro development of porcine transgenic nuclear-transferred embryos derived from newborn Guangxi Bama mini-pig kidney fibroblasts.
P2860
Q27027327-53075C81-16FE-4EBF-9665-C6AB57B2D270Q27324003-BC096E85-B4A9-483F-9352-4BCB0DCFE1CBQ27336013-2BC94A9A-944F-47DA-B540-BB93E207739AQ28067280-757BBDE7-CBDD-4FC1-B23F-7A304B6F7DCBQ30628854-24C3CDE5-B1CA-44BB-B2BA-FD59E5F976CFQ33858043-0B8C2073-ED1B-4CB1-9BD4-63BBBFB59085Q35018520-14276070-60B1-4F84-BEDD-C0547F7157DDQ35125191-9B133621-F31C-434E-B0D4-2D97C0AE48FDQ35700104-5EA4239C-470A-448C-BDEC-3D2AA02A8C9DQ35800123-1738C867-4DC4-486F-BCEC-D48CE42A0A5CQ35838047-8CEC0442-CCFD-4AE4-9CC1-B5D47107535DQ36215127-D833A056-3C15-4565-A58A-050DF8AD4EBDQ36237016-8BFEFE43-C44C-4E72-AA00-683EBE780127Q36390351-88C89F72-433E-4961-B05C-972878F7281FQ36466394-E32AD09C-F5EC-4DC9-889F-5EDEF58ACE2BQ37066644-2454EDC1-4655-4887-BF30-43288BEA93DAQ37602140-69AE2B62-893A-4B08-B8E8-BA7E528D4CACQ37759974-24A03954-7764-4F63-AEE7-4707A056987FQ37828115-3D9EFDD3-3EA0-45D3-B1F0-450DDAC81CB0Q37997627-1222BDB5-B495-4060-8999-84B5A3863A21Q38029020-DC7ADEEA-91F3-444D-8857-2216DF1B15EDQ38029031-843D3AA6-F72A-4924-A352-534BB768C4E3Q38142738-5D205CC8-1631-431A-BF4D-45B55FDA511FQ38162792-BD3E7165-A994-4BBD-90E7-40757F799336Q38714822-5C9F83B3-B6E8-40D3-B553-454C7E1A620DQ38901709-EB849B3D-3567-4944-A4BD-A34DDBB8FC14Q38985884-B3F12A5B-420F-44DE-9114-017856EB0B58Q40124315-2BFEECBE-8E61-4F6A-BDDC-F368FAF320B0Q41605343-609935A4-1470-43AE-B464-2DD0AAB96F08Q44402345-3D26BBF1-2EAE-4DE1-93FD-4ABEA384DCE5Q46181196-373259C1-15D2-4EF1-B1D1-3561E39658D6Q48662267-87176707-26B7-428D-A168-B1E8E5EEA2B3Q50107614-3492335C-60F2-4BA8-9E71-FAE75911315CQ50455542-842C88DD-2C9D-4B11-A472-7A834973E795
P2860
Dominant-negative mutant hepatocyte nuclear factor 1alpha induces diabetes in transgenic-cloned pigs.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Dominant-negative mutant hepat ...... tes in transgenic-cloned pigs.
@en
Dominant-negative mutant hepat ...... tes in transgenic-cloned pigs.
@nl
type
label
Dominant-negative mutant hepat ...... tes in transgenic-cloned pigs.
@en
Dominant-negative mutant hepat ...... tes in transgenic-cloned pigs.
@nl
prefLabel
Dominant-negative mutant hepat ...... tes in transgenic-cloned pigs.
@en
Dominant-negative mutant hepat ...... tes in transgenic-cloned pigs.
@nl
P2093
P1433
P1476
Dominant-negative mutant hepat ...... tes in transgenic-cloned pigs.
@en
P2093
Hiroshi Nagashima
Hitomi Matsunari
Hitoshi Saito
Kazuhiro Umeyama
Keizaburo Miki
Masahito Watanabe
Mayuko Kurome
Sadaaki Tohi
P2860
P2888
P304
P356
10.1007/S11248-009-9262-3
P577
2009-04-09T00:00:00Z